|
|
S Yamashita, D L Sprecher, N Sakai, Y Matsuzawa, S Tarui, D Y Hui
J Clin Invest. 1990;
86(3):688
doi:10.1172/JCI114764
Abstract |
Full text
| PDF

T
his study characterized the plasma lipoproteins of familial hyperalphalipoproteinemic patients with or without deficiency of cholesteryl ester transfer protein (CETP) activity. The subjects with CETP deficiency have increased levels of apolipoprotein (apo) E. The increased concentration of apo E in these subjects was correlated to the appearance of apo E-rich high density lipoproteins (HDL). Sodium dodecyl sulfate-polyacrylamide gel analysis revealed that these lipoproteins contained predominantly the apo E (82%) and little amount of apo A-I (18%). These apo E-rich HDL displayed a much higher affinity than human LDL in binding to LDL receptors on human fibroblasts. Furthermore, 3.5 times fewer apo E-rich HDL than LDL were required to saturate the receptors on fibroblasts. These data indicated that the apo E-rich HDL in CETP-deficient human subjects contained multiple copies of apo E and bound to the LDL receptor through multiple interactions. The apo E-rich HDL, with similar properties as cholesterol-induced apo E HDLc, were not detectable in normal human subjects or in hyperalphalipoproteinemic subjects with normal CETP activity. The apo E-containing HDL in the latter subjects were smaller and contained only small amounts of apo E (14%). The difference in apo E-containing HDL in these subjects suggests a correlation between CETP level and the appearance of apo E-rich HDL.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(48)
| Title and authors |
Publication |
Year |
Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolism
Eric J. Niesor
|
Current Opinion in Lipidology
|
2011 |
Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk Reduction
D E Gutstein, R Krishna, D Johns, H K Surks, H M Dansky, S Shah, Y B Mitchel, J Arena, J A Wagner
|
Clin Pharmacol Ther
|
2011 |
Association of ApoE and HDL-C with cardiovascular and cerebrovascular disease: potential benefits of LDL-apheresis therapy
Patrick M Moriarty
|
Clinical Lipidology
|
2009 |
Pharmacokinetic, Pharmacodynamic, and Safety Profile of a New Cholesteryl Ester Transfer Protein Inhibitor in Healthy Human Subjects
R Wolk, D Chen, R W Clark, J Mancuso, P L Barclay
|
Clin Pharmacol Ther
|
2009 |
Peroxisome Proliferator-Activated Receptor α Agonists Regulate Cholesterol Ester Transfer Protein
Thomas P. Beyer, Yanqun Chen, Regina K. Porter, Deshun Lu, Robert J. Schmidt, Nathan B. Mantlo, Robert J. Konrad, Guoqing Cao
|
Lipids
|
2008 |
HDL, ABC Transporters, and Cholesterol Efflux: Implications for the Treatment of Atherosclerosis
Alan R. Tall, Laurent Yvan-Charvet, Naoki Terasaka, Tamara Pagler, Nan Wang
|
Cell Metabolism
|
2008 |
Decreased post-prandial triglyceride response and diminished remnant lipoprotein formation in cholesteryl ester transfer protein (CETP) deficiency
Akihiro Inazu, Katsuyuki Nakajima, Takamitsu Nakano, Manabu Niimi, Masa-aki Kawashiri, Atsushi Nohara, Junji Kobayashi, Hiroshi Mabuchi
|
Atherosclerosis
|
2008 |
Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system
Blanca Ripollés Piquer, Hassan Nazih, Arnaud Bourreille, Jean Pierre Segain, Jean Michel Huvelin, Jean-Paul Galmiche, Jean-Marie Bard
|
Metabolism
|
2006 |
Effect of cholesteryl ester transfer protein (CETP) expression on diet-induced hyperlipidemias in transgenic rats
Zoulika Zak, Thomas Gautier, Laure Dumont, David Masson, Valérie Deckert, Linda Duverneuil, Jean-Paul Pais De Barros, Naig Le Guern, Martina Schneider, Philippe Moulin, Alain Bataillard, Laurent Lagrost
|
Atherosclerosis
|
2005 |
Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia
Wilfried Le Goff, Maryse Guerin, M.John Chapman
|
Pharmacology & Therapeutics
|
2004 |
|